SOURCE: Skinvisible Pharmaceuticals, Inc.

May 25, 2007 12:12 ET

CEO of Skinvisible Pharmaceuticals, Inc. to Air in Live MN1 Interview

LAS VEGAS, NV -- (MARKET WIRE) -- May 25, 2007 -- Skinvisible Pharmaceuticals, Inc., a wholly owned subsidiary of Skinvisible, Inc. (OTCBB: SKVI), will be featured in an exclusive Market News First interview May 25, 2007 at 11:00 AM CDT. Chief Executive Officer Terry Howlett will talk with MN1 hosts Saul Albom on about their Invisicare® technology and the company's place in the dermatology and topical delivery system market.

To learn more about Skinvisible Pharmaceuticals, Inc. and its investment opportunities, log on to on May 25, 2007 at 11:00 AM CDT.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its technology and formulated products to manufacturers of Rx and OTC dermatology products. See

About Invisicare®

Skinvisible has patented its technology and trademarked its polymer delivery system Invisicare®. Invisicare is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time. They are non-occlusive and allow normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. See:


Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.

This news release includes forward-looking statements regarding, among other things, the Company's business and financial plans, strategies and prospects. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, it cannot provide assurance that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as: believe, expect, anticipate, should, planned, will, may, intend, estimated, and potential, among others. Important factors that could cause actual results to differ materially from the forward-looking statements made in this news release include market conditions and those set forth in any reports or documents that the Company may publicly file from time to time. All forward-looking statements attributable to the company or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.

Contact Information


    Skinvisible Pharmaceuticals, Inc.
    Terry Howlett
    President & CEO
    (702) 433-7154

    Market News First
    Angela Junell